/Bristol-Myers%20Squibb%20Co_%20logo%20on%20phone%20by-%20Piotr%20Swat%20via%20Shutterstock.jpg)
Princeton, New Jersey-based Bristol-Myers Squibb Company (BMY) is a global biopharmaceutical company. With a market cap of $97.9 billion, the company engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products.
Companies worth $10 billion or more are generally described as “large-cap stocks”, and Bristol-Myers Squibb fits this description perfectly. The company portfolio includes key therapies in oncology, immunology, cardiovascular, and hematology. It also continues to expand its pipeline through internal R&D and strategic acquisitions.